Table 1 Patient characteristics
Characteristics | Overall population (n = 20) | CC-0 (n = 16) | CC-1+ (n = 14) | p-value | Relapse < 6 months (n = 12) | Relapse > 6 months (n = 18) | p-value |
|---|---|---|---|---|---|---|---|
Age (years) | 62.8 +/− 10.77 | 63.62 +/− 8.62 | 61.93 +/− 13.09 | 0.92 | 63.57 +/− 11.95 | 62.2 +/− 9.97 | 0.63 |
BMI (kg/m2) | 23.64 +/− 3.39 | 23.69 +/− 2.91 | 23.59 +/− 3.98 | 0.77 | 22.75 +/− 3.04 | 24.42 +/− 3.58 | 0.24 |
Gestity | 1.81 +/− 1.49 | 1.94 +/− 1.95 | 1.64 +/− 1.69 | 0.45 | 1.23 +/− 1.47 | 1.80 +/− 1.57 | 0.90 |
Parity | 1.74 +/− 1.65 | 1.75 +/− 1.24 | 1.73 +/− 2.20 | 0.51 | 1.92 +/− 1.98 | 1.60 +/− 1.40 | 0.86 |
Menopause | 27 (90 %) | 15 (93.7 %) | 12 (85.7 %) | 0.59 | 10 (83.3 %) | 17 (94.4 %) | 0.59 |
FIGO stage | 1 | 0.63 | |||||
IIIa | 1 (3.31 %) | 1 (6.25 %) | 0 | 0 | 1 (5.55 %) | ||
IIIb | 1 (3.31 %) | 1 (6.25 %) | 0 | 0 | 1 (5.55 %) | ||
IIIc | 23 (76.7 %) | 12 (75 %) | 11 (78.6 %) | 9 (75 %) | 14 (77.8 %) | ||
IV | 5 (16.67 %) | 2 (12.5 %) | 3 (21.4 %) | 3 (25 %) | 2 (11.1 %) | ||
Grading | 0.26 | 0.63 | |||||
I | 3 (10 %) | 3 (18.7 %) | 0 | 0 | 3 (16.7 %) | ||
II | 9 (30 %) | 5 (31.3 %) | 4 (35.7 %) | 5 (41.7 %) | 4 (22.2 %) | ||
III | 15 (50 %) | 6 (37.5 %) | 9 (64.3 %) | 5 (41.7 %) | 10 (55.6 %) | ||
Pre-NAC CA-125 (UI/ml) | 1762.63 [16–9453] | 1432.89 [16–9453] | 2257.25 [302–9400] | 0.05 | 1884.07 [16–9453] | 1656.8 [57–9400] | 0.15 |
Pre-NAC HE4 (pmol/l) | 985.3 [46.1–6562] | 928.22 [46.1–6562] | 984.26 [153.2–2746] | 0.24 | 1374.59 [63.9–6562] | 644.66 [46.1–2031] | 0.13 |
Cycles of NAC | 5.75 [3–7] | 5.5 [3–6] | 6.12 [6–7] | 0.08 | 5.60 [3–7] | 5.62 [4–6] | 0.69 |